Cybrexa, Inc.
1 known investors
Cybrexa Therapeutics develops a tumor-targeting platform called alphalex that enables targeted delivery of anticancer drugs directly to tumor cells independent of surface antigens. The company focuses on oncology and aims to provide new treatment options for cancer patients.
BiotechMedical Devices